POA
ACOR

Pergamon Offshore Advisors’s Acorda Therapeutics ACOR Stock Holding History

Pergamon Offshore Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-133
Closed -$532K – 204
2015
Q2 		$532K Sell
133
-23
-15% -$88.8K 0.56% 66
2015
Q1 		$623K Buy
+156
New +$714K 0.6% 59

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pergamon Offshore Advisors's ACOR Position: Q3 2015 in Review

Pergamon Offshore Advisors sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 133 shares — an estimated $532K sold.

Pergamon Offshore Advisors first reported a position in ACOR in Q1 2015 and held it in 2 quarters. The position peaked at $623K in Q1 2015. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • Pergamon Offshore Advisors reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 133 Acorda Therapeutics shares in Q3 2015, an estimated $532K.
  • Pergamon Offshore Advisors first reported a position in Acorda Therapeutics in Q1 2015 and held it in 2 quarters.
  • Pergamon Offshore Advisors's Acorda Therapeutics position peaked at $623K in Q1 2015.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.